<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR65">
 <label>65.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Emu</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Fessel</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Schrader</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Richmond</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Win</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1</article-title>
  <source>N Engl J Med</source>
  <year>2018</year>
  <volume>379</volume>
  <fpage>645</fpage>
  <lpage>654</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1711460</pub-id>
  <?supplied-pmid 30110589?>
  <pub-id pub-id-type="pmid">30110589</pub-id>
 </element-citation>
</ref>
